DOXORUBICIN 200mg/100ml (Doxorubicin SOLUTION) 200mg/100ml

Doxorubicin 200mg/100ml solution is a chemotherapy medication used for cancer treatment. This anthracycline antibiotic works by slowing or stopping cancer cell growth. Store at ambient temperature and handle with care. Not for self-administration.

Strength

200mg/100ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Sandoz

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Doxorubicin 200mg/100ml solution is primarily used to treat various cancers including breast cancer, bladder cancer, and leukemia. It may also be prescribed for Hodgkin's lymphoma, non-Hodgkin's lymphoma, and certain solid tumors. This medication is typically administered by healthcare professionals in a clinical setting. Patients often ask, 'what is doxorubicin 200mg/100ml used for' as part of cancer treatment protocols.

Side Effects

Doxorubicin 200mg/100ml solution may cause temporary side effects such as nausea, hair loss, or fatigue during treatment. Some patients experience changes in urine color or mouth sores. These effects vary by individual and are typically monitored by medical staff.

Precautions & Warnings

Handle doxorubicin 200mg/100ml solution with care due to its cytotoxic nature. Avoid direct skin contact and use protective gloves when handling. Pregnant individuals or those planning pregnancy should consult a healthcare provider before exposure. Keep out of reach of children and pets.

Avoid Interactions

Doxorubicin 200mg/100ml solution may interact with other medications, including certain chemotherapy drugs or heart medications. Alcohol consumption should be avoided during treatment. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using.

Frequently Asked Questions

Doxorubicin is generally not recommended during pregnancy due to potential risks to the fetus. Consult a healthcare provider for personalized advice.

This medication is administered intravenously by healthcare professionals in a clinical setting. Self-administration is not permitted.

Contact your healthcare provider immediately if a dose is missed. Do not attempt to self-administer a missed dose.

Alcohol consumption should be avoided during treatment with doxorubicin. Consult your doctor for specific guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.